Published Paper Details:

Adverse drug reactions (ADRs) are a major source of illness and mortality around the world. We highlight future goals for ADR research in this review, including discovering additional risk factors for ADRs, notably genetic and environmental variables. Advances in genetics and personalised medicine may aid in identifying individuals who are more likely to experience ADRs and tailoring pharmaceutical regimens accordingly. Creating biomarkers that can predict or detect ADRs could improve ADR detection and management. Large datasets can be analysed using machine learning and artificial intelligence to find patterns of ADRs and predict ADRs before they occur. Improved pharmacovigilance operations can aid in the detection and reporting of ADRs. Alternative therapies, such as herbal remedies and traditional medicines, can aid in the identification of probable ADRs and medication interactions. Involving patients in ADR research can aid in identifying patient viewpoints, preferences, and experiences with ADRs. In conclusion, future ADR research should concentrate on identifying additional risk factors, establishing personalised medicine techniques, identifying biomarkers, using machine learning and AI, improving pharmacovigilance, studying alternative medicines, and integrating patients in research. These approaches have the potential to improve drug safety as well as patient outcomes.